ACELRX PHARMACEUT. DL-01 Cash Flow Quality Index
ACELRX PHARMACEUT. DL-01 cash flow quality index. ACELRX PHARMACEUT. DL-01 (R5XA) has a Cash Flow Quality Index of -0.67x as of December 2022. Operating cash flow of €-28.33 Million is below net income of €42.33 Million, suggesting accrual-heavy earnings not yet converted to cash. See R5XA financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of ACELRX PHARMACEUT. DL-01 (2022–2022)
Cash flow quality index of ACELRX PHARMACEUT. DL-01 from 2022 to 2022. Historical Cash Flow Quality Index for ACELRX PHARMACEUT. DL-01 across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore ACELRX PHARMACEUT. DL-01 debt service capacity to assess how comfortably operating cash covers total debt obligations.
ACELRX PHARMACEUT. DL-01 Cash Flow Quality Index by Year (2022–2022)
ACELRX PHARMACEUT. DL-01 cash flow quality index by year from 2022 to 2022. Year-by-year earnings quality comparison for ACELRX PHARMACEUT. DL-01. For the full cash flow conversion analysis, see how efficiently does ACELRX PHARMACEUT. DL-01 generate cash.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -0.67x | €-28.33 Million | €42.33 Million | — |